pyrimethamine
An aminopyrimidine that is pyrimidine-2,4-diamine which is substituted at position 5 by a p-chlorophenyl group and at position 6 by an ethyl group. It is a folic acid antagonist used as an antimalarial or with a sulfonamide to treat toxoplasmosis.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
antibiotic without defined classificationARO:3000003
-
CHEBI:38338 -
CHEBI:83403 - antibiotic without defined classification
ARO:3000003
Chemical structure
| Molecular formula | C12H13ClN4 |
|---|---|
| Charge | 0 |
| Average mass | 248.717 Da |
| Monoisotopic mass | 248.08287 Da |
| Source | ChEBI |
| InChIKey | WKSAUQYGYAYLPV-UHFFFAOYSA-N |
CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1
InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)16-9)7-3-5-8(13)6-4-7/h3-6H,2H2,1H3,(H4,14,15,16,17)
Also called
- pirimetamina
- pyrimethaminum
- pyriméthamine
- 5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine
- 2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine
- 2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine
- 2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine
- 5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine
- 5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine
- 5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine
- CD
- Chloridine
- Chloridyn
- Diaminopyritamin
- Ethylpyrimidine
- Primethamine
- chloridin
- diaminopyritamin
- pirimecidan
- pirimetamin
- pyrimethamin
Cross-references
- pyrimethamine
ARO:3009163 - cas:58-14-0
- hmdb:HMDB0014350
- kegg.compound:C07391
- lincs.smallmolecule:LSM-3967
- pdb-ccd:CP6
- reaxys:219864
- vsdb:1912
- chembl:CHEMBL36
- pubchem.compound:4993
Drug registries
Patents and articles
Activity roles
- antiprotozoal drug
CHEBI:35820 - antimalarial
CHEBI:38068
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:3009163 |
pyrimethamine | antibioticmech:aro-e7e60b9586 |
2026-08-30 |
| CHEBI | CHEBI:8673 |
pyrimethamine | antibioticmech:chebi-389df716d8 |
2026-08-30 |
Mechanism summary
- Mode of action
- FOLATE_PATHWAY_INHIBITION host shared target
- Clinical status
- APPROVED
Resistance mechanisms
ANTIBIOTIC_TARGET_ALTERATION 2
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Pneumocystis jerovecii dhfr with mutations associated with resistance to Trimethoprim sulfamethoxazole combined with Pyrimethamine atovaquone | ARO:3009290 | — | ||
| Pneumocystis jerovecii dhfr with mutations associated with resistance to pyrimethamine-sulfadoxine | ARO:3009285 | — |
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (ARO, CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories